Transfer of dendritic cells (DC) ex vivo stimulated with interferon- gamma (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (nod) mice

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 38-43

  Shinomiya, Mizuho ^a   Fazle Akbar, S M ^a   Shinomiya, H ^a   Onji, M ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adoptive transfer; Antigen presenting cells; Insulin dependent diabetes mellitus; Insulitis

Indexed keywords

GAMMA INTERFERON; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL TRANSFER; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOID TISSUE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTERFERON TYPE II; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; MICE, INBRED NOD;

EID: 0033011514     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00947.x     Document Type: Article

References (39)

1. Bach JF. Insulin-dependent diabetes mellitus. Curr Opin Immunol 1991: 3:902-5.
2. Atkinson MA, Maclare NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331:1428-36.
3. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85:291-7.
4. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992; 51:285-322.
5. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulatioa gets the NOD. Immunity 1997; 7:727-38.
6. O'Reilly LA, Huchings PR, Crocker PR et al. Characterization of pancreatic islet cell infiltration in NOD mice: Effect of cell transfer and transgene expression. Eur J Immunol 1991; 21:1171-80.
7. Jansen AF, Homo-Delarche H, Hooijkaas PJ, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β-cell destruction in NOD mice. Diabetes 1994; 43:667-75.
8. Miyazaki A, Hanafusa T, Yamada K et al. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study. Clin Exp Immunol 1985; 60:622-30.
9. + T cells. J Exp Med 1987; 166:823-32.
10. + islet-specific T cell clone. Science 1990; 249:1433-6.
11. Semoe P, Bedossa P, Richard MF, Villa MC, Bach JF, Boitard C. Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol 1991; 21:1163-9.
12. Hart DNJ. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997; 90:3245-87.
13. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
14. Knight SC, Farrant J, Chan J, Bryant H, Bedford PH, Bateman C. Induction of autoimmunity with dendritic cells: Studies on thyroiditis in mice. Clin Immunol Immunopathol 1988; 48:277-89.
15. Ridgway WM, Fasso M, Lanctot A, Garvey C, Fathman CG. Breaking self-tolerance in nonobese diabetic mice. J Exp Med 1996; 183:1657-62.
16. Harada M, Kishimoto Y, Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 1990; 8:85-89.
17. Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanuc ER. A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc Natl Acad Sci USA 1992; 89:3927-31.
18. Crowley M, Inaba K, Witmar-Pack M, Steinman RM. The cell surface of mouse dendritic cells from different tissue including thymus. Cell Immunol 1989; 118:108-25.
19. Kupiec-Weglinski JW, Austin JM, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from the Blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med 1988; 167:632-45.
20. Dewanjee MK, Rao SA, Didisheim P. Indium-III tropolone, a new high-affinity platelet label: Preparation and evaluation of labeling parameters. J Nucl Med 1981; 12:981-7.
21. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993; 150:2534-43.
22. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993; 90:9625-9.
23. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cell in type I diabetes. Lancet 1995; 345:491-2.
24. Guery JC, Adorini L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 1995; 154:536-44.
25. Ranjeny R, Lipsky PE. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Immunol Today 1996; 17:559-64.
26. Larsen CP, Ritchie SC, Hendrix R et al. Regulation of immunostimulatory function and costimulatory molecule (BT-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152:5208-19.
27. Wicker LS, Miller BJ, Coker LZ et al. Genetic control of diabetes and insulitis in the non-obese diabetic (NOD) mouse. J Exp Med 1987; 165:1639-54.
28. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 1996; 156:450-8.
29. Clare-Salzler MJ, Brooks J, Chai A, Herle KV, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90:741-8.
30. Nicoletti F, Zaccone P, Marco RD et al. Paradoxical antidiabetogenic effect of γ-interferon in DP-BB rats. Diabetes 1998; 47:32-38.
31. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34-38.
32. Hinrichs DJ, Wegmann KW, Dietsch GN. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. J Exp Med 1987; 166:1906-11.
33. Farrant J, Bryant AE, Chan J, Hinswonh RL. Thyroglobulin treated blood dendritic cells reduce IgG anti-thyroglobulin antibody in vitro in Hashimoto's thyroiditis. Immunol Immunopathol 1986; 41:433-41.
34. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996; 157:1406-14.
35. Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183:1789-96.
36. Giampiero G, Ricciardi-Castagnoli P. Dendritic cells hold promise for immunotherapy. Immunol Today 1997; 18:102-4.
37. Verge CF, Gianani, R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45:926-33.
38. Totta F, Gianani R, Previti M et al. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes 1996, 45:1193-6.
39. Shinorniya H, Shinomiya M, Stevenson GW, Stevenson HC. Activated killer monocytes: Preclinical model systems. In: Stevenson HC, ed. Adoptive Cellular Immunotherapy of Cancer (Immunology Series 48). New York: Marcel Dekker, 1989:127-38.